Agarwal Arjun sold ORKA
August 13, 2026 · Form 4 insider transaction
Agarwal Arjun sold 2,358 shares of Oruka Therapeutics, Inc. at $108.46 per share, a transaction worth $255.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
2,358
Price
$108.46
Total value
$255.8K
InsiderAgarwal Arjun
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 13, 2026
Filing dateAugust 14, 2026
Shares owned after15,312
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on February 11, 2026.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.24 to $108.71, inclusive.